Financial_NNP calendar_NN 5_CD May_NNP 2004_CD Annual_JJ General_NNP Meeting_VBG Shareholder_NN information_NN Ownership_NN structure_NN Holdings_NNS by_IN size_NN as_IN at_IN 31_CD December_NNP 2003_CD Size_NN of_IN shareholding_NN Number_NN of_IN %_NN of_IN Number_NN of_IN %_NN of_IN ordinary_JJ shares_NNS holdings_NNS total_VBP holdings_NNS ordinary_JJ shares_NNS Over_IN 1,000,000_CD 108_CD 1.09_CD 589,069,757_CD 83.58_CD 100,001_CD 1,000,000_CD 243_CD 2.45_CD 81,743,202_CD 11.59_CD 10,001_CD -_: 100,000_CD 669_CD 6.75_CD 20,971,084_CD 2.98_CD 5,001_CD -_: 10,000_CD 513_CD 5.18_CD 3,592,948_CD 0.51_CD 1,001_CD -_: 5,000_CD 3,327_CD 33.57_CD 7,066,047_CD 1.00_CD 501_CD 1,000_CD 2,240_CD 22.61_CD 1,657,137_CD 0.24_CD 1_CD 500_CD 2,809_CD 28.35_CD 739,148_CD 0.10_CD 9,909_CD 100.00_CD 704,839,323_CD 100.00_CD Directors_NNS Mr_NNP D_NNP H_NNP Brydon_NNP CBE_NNP Non-executive_JJ Chairman_NNP Mr_NNP J_NNP Fr_NNP Odfjell_NNP Non-executive_JJ Deputy_NNP Chairman_NNP Sir_NNP William_NNP Castell_NNP Chief_NNP Executive_NNP Mr_NNP G_NNP W_NNP Battersby_NNP Director_NNP of_IN Human_NNP Resources_NNP Dr_NNP A_NNP Carr_NNP President_NNP ,_, Amersham_NNP Biosciences_NNP Mr_NNP G_NNP F_NN B_NNP Kerr_NNP Finance_NNP Director_NNP Mr_NNP P_NNP Loescher_NNP Chief_NNP Operating_NNP Officer_NNP Mr_NNP D_NNP Challen_NNP CBE_NNP Non-executive_JJ Director_NNP ,_, appointed_VBN 5_CD August_NNP 2003_CD Mr_NNP J_NNP H_NNP Johansen_NNP Non-executive_JJ Director_NNP ,_, employee_NN representative_NN Dr_NNP J_NNP S_NNP Patterson_NNP Non-executive_JJ Director_NNP Professor_NNP Sir_NNP Keith_NNP Peters_NNP Non-executive_JJ Director_NNP Mr_NNP J_NNP F_NN Rejeange_NNP Non-executive_JJ Director_NNP Professor_NNP E_NNP Thorsby_NNP Non-executive_JJ Director_NNP Professor_NNP M_NNP Uhlen_NNP Non-executive_JJ Director_NNP Secretary_NNP and_CC Registered_NNP Office_NNP Mr_NNP R_NNP E_NNP B_NNP Allnutt_NNP Amersham_NNP Place_NNP Little_NNP Chalfont_NNP Buckinghamshire_NNP HP7_NNP 9NA_NNP Telephone_NNP 44_CD 0_CD 1494Â 544000_CD Registered_NNP in_IN England_NNP Wales_NNP No_NNP 1002610_CD 76_CD CAUTIONARY_NNP STATEMENT_NNP FOR_IN PURPOSES_NNPS OF_IN THE_DT SAFE_JJ HARBOR_NN PROVISIONS_NNS OF_IN THE_DT UNITED_NNP STATES_NNS PRIVATE_VBP SECURITIES_NNS LITIGATION_NNP REFORM_NNP ACT_NNP OF_IN 1995_CD The_DT Private_JJ Securities_NNPS Litigation_NNP Reform_NNP Act_NNP of_IN 1995_CD provides_VBZ for_IN a_DT safe_JJ harbor_NN for_IN forward-looking_JJ statements_NNS ._.
This_DT report_NN contains_VBZ words_NNS such_JJ as_IN believe_VBP ,_, expect_VBP and_CC anticipate_VBP and_CC similar_JJ expressions_NNS ,_, that_IN identify_VB forward-looking_JJ statements_NNS ,_, which_WDT reflect_VBP the_DT groups_NNS views_NNS about_IN future_JJ events_NNS and_CC financial_JJ performance_NN ._.
Such_JJ forward-looking_JJ statements_NNS relate_VBP to_TO the_DT outlook_NN of_IN Amersham_NNP plc_NN ,_, including_VBG in_IN particular_JJ ,_, the_DT expected_VBN growth_NN of_IN certain_JJ of_IN the_DT groups_NNS products_NNS or_CC the_DT markets_NNS for_IN those_DT products_NNS and_CC the_DT impact_NN of_IN currency_NN movements_NNS during_IN 2004_CD ._.
Actual_JJ results_NNS could_MD differ_VB materially_RB from_IN those_DT projected_VBN in_IN such_JJ forward_RB looking_VBG statements_NNS as_IN a_DT result_NN of_IN various_JJ factors_NNS that_WDT may_MD be_VB beyond_IN the_DT control_NN of_IN the_DT group_NN ._.
The_DT following_VBG important_JJ factors_NNS could_MD cause_VB actual_JJ results_NNS to_TO differ_VB materially_RB from_IN those_DT projected_VBN or_CC implied_VBN in_IN any_DT forward-looking_JJ statements_NNS :_: i_FW Changes_NNS in_IN demand_NN for_IN the_DT products_NNS of_IN Amersham_NNP plc_NN worldwide_NN or_CC the_DT markets_NNS for_IN those_DT products_NNS as_RB well_RB as_IN changes_NNS in_IN managements_NNS expectation_NN of_IN the_DT development_NN of_IN new_JJ markets_NNS and_CC the_DT timing_NN of_IN completion_NN of_IN various_JJ trials_NNS leading_VBG to_TO the_DT introduction_NN of_IN new_JJ products_NNS :_: ii_FW Changes_NNS in_IN the_DT cost_NN or_CC supply_NN of_IN raw_JJ materials_NNS ,_, changes_NNS in_IN interest_NN rates_NNS and_CC the_DT impact_NN of_IN competition_NN :_: and_CC iii_FW Price_NN controls_NNS and_CC price_NN reductions_NNS ,_, fluctuations_NNS in_IN exchange_NN rates_NNS for_IN foreign_JJ currencies_NNS ,_, changes_NNS in_IN governmental_JJ regulation_NN ,_, and_CC the_DT risk_NN of_IN loss_NN of_IN patents_NNS or_CC trademarks_NNS ._.
Accordingly_RB ,_, readers_NNS are_VBP cautioned_VBN not_RB to_TO place_VB undue_JJ reliance_NN on_IN these_DT forward-looking_JJ statements_NNS ._.
In_IN any_DT event_NN ,_, these_DT statements_NNS speak_VBP only_RB as_IN of_IN the_DT date_NN on_IN which_WDT they_PRP are_VBP made_VBN ,_, and_CC the_DT group_NN does_VBZ not_RB undertake_VB any_DT obligation_NN to_TO update_VB or_CC revise_VB any_DT of_IN them_PRP ,_, whether_IN as_IN a_DT result_NN of_IN new_JJ information_NN ,_, future_JJ events_NNS or_CC otherwise_RB ._.
